Dr. Marshal E. Lieberfarb
/content/dam/asset-migration/headshots/us-doctor-headshots/US_Oncology_Head_shot_GA_Marshal_Lieberfarb.jpg

Marshal E. Lieberfarb

Marshal E. Lieberfarb
Marshal E.
Lieberfarb
MD, PhD
Radiation Oncologist

Languages spoken

English

Expert in

Diagnostics

Interested in

Prostate, Breast, Lung, Colorectal, Head and Neck Malignancies

Overview

Centers

Coral Springs (Radiation oncology)
Coral Springs (Radiation oncology)

2101 Riverside Drive Suite 101
Coral Springs, Florida 33071

26.256599280976623, -80.23655295767183
/en/our-locations/coral-springs-cso

Well trained in the latest cutting edge technologies in radiation therapy, Dr. Marshal Lieberfarb treats patients with a variety of cancers, including breast, lung, gastrointestinal, and gynecologic malignancies. He has written and published numerous basic science and medical oncology articles in well-recognized, peer-reviewed journals. Examples of Dr. Lieberfarb’s medical research include a genetic analysis of prostate cancer as well as several clinical contributions to the medical management of prostate cancer.

Career positions

Current position(s)

  • GenesisCare - Medical Director, Southeast Florida, Pembroke Pines, FL

Past position(s)

  • GenesisCare - Radiation Oncologist, Fort Lauderdale, FL
  • Aventura Medical Center - Clinical Radiation Oncologist, Aventura, FL
  • Holy Cross Hospital - Clinical Radiation Oncologist, Fort Lauderdale, FL

Education

Universities

  • Massachusetts Institute of Technology, BS, Biology, Cambridge, MA
  • University of Stony Brook Graduate School of Pharmacology & School of Medicine, Doctor of Medicine, Stony Brook, NY

Residencies

  • Harvard Joint Center for Radiation Therapy, Radiation Oncology, Boston, MA

Internships

  • Harvard Medical School, Mt. Auburn Hospital, Internal Medicine, Cambridge, MA

Professional association

Accomplishments

Awards

  • Alpha Omega Alpha Medical Honor Society
  • Marvin Kuschner Award for Overall Excellence in Medical School

Publications

  • Simultaneous Integrated Boost (SIB) for Advanced Head and Neck (H&N) Cancer May Accelerate Muscle Loss in Concurrent Chemoradiation as Assessed by a Validated CT-Based Tool
  • Multicenter Assessment of Stereotactic Body Radiation Therapy (SBRT) Boost in Intermediate-Risk Prostate Cancer: Biochemical Failure and Toxicity

Thank you for submitting.

We will be in touch within 24 hours.

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

Our staff will provide answers to your questions within 24 hours. Otherwise, if you have a medical emergency please call 911.

*Indicates a required field